1. ICD-10-CM Codes
›
2. C00-D49
›
3. C81-C96
›
4. C95-
›
5. 2023 ICD-10-CM Diagnosis Code C95.90

2023 ICD-10-CM Diagnosis Code C95.90

Leukemia, unspecified not having achieved remission

2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

• C95.90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
• The 2023 edition of ICD-10-CM C95.90 became effective on October 1, 2022.
• This is the American ICD-10-CM version of C95.90 - other international versions of ICD-10 C95.90 may differ.

• Cancer, hematologic
• Leukemia
• Leukemia, subacute
• Malignant tumor of lymphoid hemopoietic and related tissue
• Subacute leukemia

• A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.
• A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (from the merck manual, 2006)
• A progressive, proliferative disease of blood cells, originating from myeloid or lymphoid stem cells.
• Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream.
• Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work.there are different types of leukemia, including
  • acute lymphocytic leukemia
  • acute myeloid leukemia
  • chronic lymphocytic leukemia
  • chronic myeloid leukemia
  leukemia can develop quickly or slowly. Chronic leukemia grows slowly. In acute leukemia, the cells are very abnormal and their number increases rapidly. Adults can get either type; childen with leukemia most often have an acute type.some leukemias can often be cured. Other types are hard to cure, but you can often control them. Treatments may include chemotherapy, radiation and stem cell transplantation. Even if symptoms disappear, you might need therapy to prevent a relapse. nih: national cancer institute
• Progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow; classified according to degree of cell differentiation as acute or chronic, and according to predominant type of cell involved as myelogenous or lymphocytic.

• 820 Lymphoma and leukemia with major o.r. Procedures with mcc
• 821 Lymphoma and leukemia with major o.r. Procedures with cc
• 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
• 823 Lymphoma and non-acute leukemia with other procedures with mcc
• 824 Lymphoma and non-acute leukemia with other procedures with cc
• 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
• 840 Lymphoma and non-acute leukemia with mcc
• 841 Lymphoma and non-acute leukemia with cc
• 842 Lymphoma and non-acute leukemia without cc/mcc

Convert C95.90 to ICD-9-CM

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.